Transactivation of EGFR by LCK underlies an activity-defined dependency that predicts response to EGFR inhibition in cholangiocarcinoma
Cholangiocarcinoma (CCA) is an aggressive biliary tract malignancy with limited molecularly guided treatment options. The Src-family kinase LCK is a therap